Combination Therapy of RFA and Miriplatine Versus RFA for HCC larger than 3cm
Not Applicable
- Conditions
- HCC larger than 3cm
- Registration Number
- JPRN-UMIN000004523
- Lead Sponsor
- Osaka city University Graduate School of Medicine Department of Hepatotlogy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
I.Patients who are considered not to participate in the study by physicians II.Patients with moderate or severe infections III.Patients with uncontrolled diabetes or obstruction IV.Pregnancy, nursing, or woman who may become pregnant V.Patients with a history of hypersensitivity to drugs or contrast agents containing iodine VI.Patients with a history of myocardial infarction within 3 month
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method